Pomegranate The Savier of ovarian cancer

  • Unique Paper ID: 184028
  • Volume: 12
  • Issue: 3
  • PageNo: 4095-4104
  • Abstract:
  • Ovarian cancer is the fifth most common cause of death for women overall and the leading cause of death for women diagnosed with gynecological cancers. The majority of cases are diagnosed at an advanced stage, which results in poor outcomes for this disease. The key early detection strategies include transvaginal ultrasound, a laboratory marker such as the cancer antigen-125 assay, and a detailed gynecological evaluation; however, anti-angio genic bevacizumab and Poly (ADP-ribose) polymerase (PARP) inhibitors have gained traction in the management of this gynecological malignancy in the last ten years. After the initial treatment, a high rate of recurrence has been noted. The majority of these relapsed cases are known to have a higher rate of treatment failures and are less treatable. Therefore, there is an urgent need for innovative treatment methods based on a deeper understanding of the molecular characteristics of this malignancy as well as efficient preventive and detection strategies. In addition to reviewing the epidemiology and risk factors of ovarian cancer, this article discusses some recent ongoing studies and emphasizes the evaluation and multidisciplinary approach in the care of this condition. We use here pomegranate

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{184028,
        author = {Adsul Samruddhi Subhash and Wable Madhuri Sanjay and Garud Harshada Sudam and Mane Bharati Baban and Bhand Revannath Narayan and Gayke Sanket Ramesh and Bramhane Omkar Bapurao and Sonone Sumit Pravin},
        title = {Pomegranate The Savier of ovarian cancer},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {3},
        pages = {4095-4104},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=184028},
        abstract = {Ovarian cancer is the fifth most common cause of death for women overall and the leading cause of death for women diagnosed with gynecological cancers. The majority of cases are diagnosed at an advanced stage, which results in poor outcomes for this disease. The key early detection strategies include transvaginal ultrasound, a laboratory marker such as the cancer antigen-125 assay, and a detailed gynecological evaluation; however, anti-angio genic bevacizumab and Poly (ADP-ribose) polymerase (PARP) inhibitors have gained traction in the management of this gynecological malignancy in the last ten years. After the initial treatment, a high rate of recurrence has been noted. The majority of these relapsed cases are known to have a higher rate of treatment failures and are less treatable. Therefore, there is an urgent need for innovative treatment methods based on a deeper understanding of the molecular characteristics of this malignancy as well as efficient preventive and detection strategies. In addition to reviewing the epidemiology and risk factors of ovarian cancer, this article discusses some recent ongoing studies and emphasizes the evaluation and multidisciplinary approach in the care of this condition.
We use here pomegranate},
        keywords = {Ovarian  cancer, Pomegranate, Menopause,Tumor},
        month = {September},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 12
  • Issue: 3
  • PageNo: 4095-4104

Pomegranate The Savier of ovarian cancer

Related Articles